Inflammatory leptomeningeal cytokines mediate COVID-19 neurologic symptoms in cancer patients. Remsik, Wilcox et al.
Published: 7 January 2021| Version 1 | DOI: 10.17632/s7m535k6nt.1
Contributor:
Jan Remsik
Description
Targeted proteomics analyses of cerebrospinal fluid from four patient cohorts, as described in Remsik, Wilcox et al.
Files
Institutions
Memorial Sloan Kettering Cancer Center
Categories
Neurology, Neuroimmunology, Neuro-Inflammation, COVID-19